Cargando…
Efficacy of Additional Corticosteroids After Dexamethasone Treatment for Moderate to Severe COVID-19: An Observational Study
Background Previous studies have demonstrated dexamethasone (DEX)'s efficacy for coronavirus disease 2019 (COVID-19). In contrast, patients with residual lung field shading and symptoms after DEX treatment have been observed, and the efficacy of additional corticosteroids (AC) is unknown. Objec...
Autores principales: | Fukuda, Yosuke, Mochizuki, Kaoru, Ijichi, Miharu, Homma, Tetsuya, Tanaka, Akihiko, Sagara, Hironori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487281/ https://www.ncbi.nlm.nih.gov/pubmed/37692586 http://dx.doi.org/10.7759/cureus.43179 |
Ejemplares similares
-
Endobronchial Metastases in Lung Cancer Harboring EML4-ALK Rearrangement
por: Ijichi, Miharu, et al.
Publicado: (2022) -
Successful treatment of extensive-stage small cell lung cancer with concurrent pleural and pericardial effusions: Case report
por: Kashima, Ayaka, et al.
Publicado: (2022) -
Sarcoidosis or Tuberculosis: Should Corticosteroids Be Used?
por: Shen, Yuting, et al.
Publicado: (2023) -
Activities of Serum Ferritin and Treatment Outcomes Among COVID-19 Patients Treated With Vitamin C and Dexamethasone: An Uncontrolled Single-Center Observational Study
por: Burugu, Hemanth Reddy, et al.
Publicado: (2020) -
Clinical inertia in asthma
por: Fukuda, Yosuke, et al.
Publicado: (2023)